Melanotan II is a synthetic analogue of -MSH, acting as a non-selective melanocortin receptor agonist
Storage 4C, protect from light, stored under nitrogen * The compound is unstable in solutions, freshly prepared is recommended
Ongoing research highlights the potential of combination therapies and emerging agents that address immune response, inflammation, and fibrosis, offering hope for improved long-term outcomes in PBC management
Similarly, treatment of perfused mouse islets with Exendin 9-39 decreased GSIS, but Ado, a selective glucagon receptor antagonist, had no effect on GSIS (36), demonstrating that the effect of alpha-cell-derived proglucagon products to increase insulin secretion does not necessitate signaling through the GCGR
Mobile appointments may be available at a residence, office, or hotel depending on location, scheduling, and clinical appropriateness